Data submission formats for omics studies

Introduction

Omics studies involve the comprehensive analysis of biological molecules, including genes, proteins, metabolites, and other molecular components of living organisms. Major branches include genomics, transcriptomics, proteomics, metabolomics, epigenomics, and microbiomics. These studies generate large volumes of complex scientific data that must be properly organized, documented, stored, and submitted to research institutions, scientific repositories, regulatory authorities, and academic journals.

Data submission formats refer to standardized structures and technical requirements used to present omics research information. They ensure that scientific datasets can be accessed, interpreted, analysed, and reproduced by other researchers.

Proper data submission is essential for scientific transparency, research reproducibility, regulatory compliance, intellectual property protection, and responsible sharing of biological information.

Meaning and importance of standardized data formats

Standardized data submission formats establish common technical and documentation requirements for uploading omics datasets to scientific databases and research repositories.

Their main objectives include:

Data consistency: Ensuring that information follows recognized scientific structures and terminology.

Research reproducibility: Allowing independent researchers to verify experimental findings.

Interoperability: Enabling different laboratories and research platforms to exchange information.

Scientific transparency: Supporting the verification of published research results.

Regulatory accountability: Providing reliable documentation for biotechnology products and clinical investigations.

For example, a genomics research institution submitting DNA sequencing results must provide sequence files, sample information, experimental methods, and relevant metadata in recognized formats.

Major data submission formats in omics research

Different omics disciplines use specialized formats according to the nature of the biological information.

1. Genomics data

Genomics studies commonly use FASTQ files for raw sequencing reads, FASTA files for nucleotide sequences, and BAM or CRAM files for aligned sequencing data. Variant information may be submitted using VCF files.

2. Transcriptomics data

RNA sequencing studies commonly use FASTQ files for raw reads and count matrices for gene expression analysis. Researchers may also provide normalized expression datasets and associated metadata.

3. Proteomics data

Proteomics research uses formats such as mzML, mzIdentML, and mzTab to represent mass spectrometry measurements, peptide identification, and protein analysis results.

4. Metabolomics data

Metabolomics studies frequently use formats such as mzML, mzXML, and nmrML. These formats support the submission and interpretation of mass spectrometry and nuclear magnetic resonance data.

5. Microbiomics data

Microbiome studies may use FASTQ files, FASTA files, and standardized taxonomic or abundance tables. Researchers also provide information about sample collection, DNA extraction, sequencing methods, and analytical pipelines.

Legal framework in India

India does not have a single statute prescribing one mandatory data submission format for all omics studies. However, several laws and research guidelines regulate the collection, documentation, storage, and sharing of biological research data.

The Digital Personal Data Protection Act, 2023 is relevant when omics datasets contain identifiable personal information. Genetic and other biological datasets must be handled in accordance with applicable requirements concerning lawful processing, consent, security safeguards, and erasure.

The ICMR National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 establish ethical requirements for research involving human biological samples and associated information. They emphasize informed consent, confidentiality, responsible data management, and research ethics committee oversight.

The New Drugs and Clinical Trials Rules, 2019 are relevant when omics studies form part of regulated clinical trials or investigations involving new drugs. Appropriate scientific documentation and regulatory records must be maintained.

The Biological Diversity Act, 2002, as amended, may also apply when research involves biological resources obtained from India, depending on the nature of the research, the parties involved, and applicable exemptions.

International legal and scientific framework

The FAIR Data Principles require research data to be Findable, Accessible, Interoperable, and Reusable. These principles encourage standardized metadata, recognized identifiers, and appropriate documentation.

The International Nucleotide Sequence Database Collaboration (INSDC) coordinates major nucleotide sequence repositories, including GenBank, the European Nucleotide Archive, and the DNA Data Bank of Japan.

The ProteomeXchange Consortium establishes standards for submitting and sharing proteomics datasets through participating repositories.

The Metabolomics Standards Initiative (MSI) promotes standardized reporting of metabolomics experiments and analytical results.

These frameworks are primarily scientific and technical standards rather than legislation, but they significantly influence research publication and data-sharing practices.

Important case laws

Direct Indian judicial decisions specifically concerning omics data submission formats are limited. However, the following judgments establish relevant principles concerning privacy, scientific evidence, and biological information.

1. Justice K.S. Puttaswamy v. Union of India (2017)

The Supreme Court of India recognized privacy as a fundamental right under Article 21. The judgment is relevant when researchers submit genomic, transcriptomic, or other biological datasets containing identifiable personal information. It supports appropriate privacy safeguards and responsible information sharing.

2. Samira Kohli v. Dr. Prabha Manchanda (2008)

The Supreme Court emphasized the importance of informed consent in medical treatment. Its principles are relevant when researchers collect and submit biological samples or associated personal information for research purposes beyond the original medical purpose.

3. S. and Marper v. United Kingdom (2008)

The European Court of Human Rights held that indefinite retention of DNA profiles and fingerprints of individuals who had not been convicted violated Article 8 of the European Convention on Human Rights. The decision demonstrates the importance of protecting genetic information throughout its storage and use.

4. Daubert v. Merrell Dow Pharmaceuticals, Inc. (1993)

The United States Supreme Court established standards for assessing scientific expert evidence, including testability, peer review, error rates, and general acceptance. These considerations are relevant when evaluating the reliability of omics research results presented as scientific evidence.

Essential requirements for omics data submission

Research institutions should establish the following practices:

Use recognized file formats appropriate to each omics discipline.

Provide complete metadata describing samples, experimental conditions, and analytical methods.

Maintain consistent sample identifiers and data version records.

Validate files before submission to scientific repositories.

Document sequencing platforms, laboratory protocols, and analytical software.

Remove unnecessary personal identifiers from shared datasets.

Apply appropriate access restrictions to sensitive human genomic information.

Maintain accurate records of consent, ethical approvals, and data transfers.

Challenges and conclusion

Omics data submission faces challenges involving large file sizes, incompatible technologies, inconsistent metadata, privacy risks, and differences in international repository requirements. Human genomic datasets create additional concerns because they may reveal information about individuals and their biological relatives.

Therefore, researchers must balance scientific openness with confidentiality, informed consent, and applicable legal obligations. Indian data protection law, ICMR ethical guidelines, international repository standards, and scientific reporting frameworks provide an important foundation for responsible omics data management. Standardized formats, complete metadata, secure repositories, and reproducible analytical procedures improve scientific reliability and encourage responsible biotechnology innovation.